Difficulty: Medium
Average Score: 63%
Practice
All are lines of treatment for hyperkalemia Except:
Correct answer
B
Rationale
In the management of hyperkalemia, it is crucial to understand the appropriate lines of treatment to prevent serious complications. The correct answer, B) Beta blockers, is not a typical treatment for hyperkalemia. Beta blockers do not directly impact potassium levels in the body and are not indicated for managing hyperkalemia.
A) Calcium gluconate IV is used to stabilize cardiac cell membranes in severe hyperkalemia to prevent cardiac arrhythmias. C) Sodium bicarbonate is used in cases of metabolic acidosis associated with hyperkalemia to help shift potassium into cells. D) Sodium polystyrene sulfonate (Kayexalate) is a cation-exchange resin that helps remove potassium from the body through the gastrointestinal tract.
Educationally, understanding the treatment options for hyperkalemia is vital for pediatric nurses to provide safe and effective care to pediatric patients. Nurses must be able to recognize the signs and symptoms of hyperkalemia and implement appropriate interventions promptly to prevent life-threatening complications. It is important to continuously update knowledge on pediatric pharmacology and treatment guidelines to ensure optimal patient outcomes.
A) Calcium gluconate IV is used to stabilize cardiac cell membranes in severe hyperkalemia to prevent cardiac arrhythmias. C) Sodium bicarbonate is used in cases of metabolic acidosis associated with hyperkalemia to help shift potassium into cells. D) Sodium polystyrene sulfonate (Kayexalate) is a cation-exchange resin that helps remove potassium from the body through the gastrointestinal tract.
Educationally, understanding the treatment options for hyperkalemia is vital for pediatric nurses to provide safe and effective care to pediatric patients. Nurses must be able to recognize the signs and symptoms of hyperkalemia and implement appropriate interventions promptly to prevent life-threatening complications. It is important to continuously update knowledge on pediatric pharmacology and treatment guidelines to ensure optimal patient outcomes.